• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.33% Nasdaq Up 0.52%

    Janus Global Life Sciences D (JNGLX)

    61.51 Down 1.57(2.49%) Jun 29
    Prev Close:61.51
    YTD Return*:18.65%
    Net Assets*:4.83B
    Yield*:N/A

    * As of 31-May-15

    Quotes delayed, except where indicated otherwise. Currency in USD.

    Top Holdings

    Symbol% AssetsYTD Return %
    JNJ2.98N/A
    AMGN2.82N/A
    BIIB2.71N/A
    ACT.IR2.41N/A
    VRX.TO2.37N/A

    Fund Basics

    Morningstar Overall Rating:
    Total Assets:4.83B
    Category:Health
    Annual Report Expense Ratio (net):0.84%

    Performance & Risk

    YTD Return:18.65%
    5y Avg Return:31.09%
    Rank in Category (ytd):20
    % Rank in Category (ytd):15.27%
    Beta (3y):0.58
    Morningstar Risk Rating:3

    Fund Summary

    The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback